A new medication tracking system is hoped to alleviate the gray market that thrives through diverting medications, as some hospitals and clinics (facing recent drug shortages) have turned to middle-men brokers. However, this increases the risk of counterfeit or unsafe drugs being administered to patients, FDA officials say. Counterfeit or altered medications can be diluted, inert or dangerous.
